On Sept. 23, 2020, the Department of Health and Human Services (HHS) announced upcoming action by the Centers…
On Sept. 22, 2020, the NIH announced that two randomized, placebo-controlled clinical trials expanded enrollment to further evaluate…
On Sept. 17, 2020, Rigel Pharma announced the start of a multicenter, Phase 2 trial to evaluate the…
On Sept. 16, 2020, the National Institutes of Health (NIH) announced a $12 million award for outreach and…
On Sept. 15, 2020, the National Institutes of Health (NIH) awarded seven contracts worth a total of $22.8…
On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
On Sept. 15, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced that a study…
On Sept. 14, 2020, the National Institutes of Health (NIH) announced that it had added funding for more…
On Sept. 14, 2020, Eli Lilly and Incyte announced initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2)…
On Sept. 10, 2020, the National Institutes of Health launched two of three adaptive Phase 3 clinical trials…
On Sept. 9, 2020, the National Institutes of Health (NIH) announced that after nearly 15 years on an…
On Sept. 8, 2020, researchers at Albert Einstein College of Medicine, led by Ana Maria Cuervo, M.D., Ph.D.,…
On Sept. 3, 2020, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) had…
On Sept. 2, 2020, the National Institutes of Health (NIH) announced $129.3 million in scale-up and manufacturing support…
On Sept. 2, 2020, Aegis Sciences announced that it had been selected to participate in the National Institutes…
On Sept. 2, 2020, PathGroup announced the award of a funding grant from the National Institutes of Health…
On Sept. 2, 2020, Sonic Healthcare USA was awarded a contract from the National Institutes of Health (NIH)…
On Sept. 2, 2020, MicroGEM announced it had been awarded up to $40.9 million by the National Institutes…
On Sept. 1, 2020, Humanigen announced the first case-control data of lenzilumab in severe COVID-19 demonstrated an 80%…
On Aug. 31, 2020, An international team of scientists supported by the National Institute on Alcohol Abuse and…
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
On Aug. 20, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…
On Aug. 19, 2020, the National Institutes of Health (NIH) announced it was requiring a small nonprofit research…
On Aug. 18, 2020, the National Institutes of Health (NIH) awarded Albert Einstein College of Medicine and Montefiore…
On Aug. 14, 2020, research supported by the National Institutes of Health (NIH) delineated how two relatively common…
On Aug. 13, 2020, the National Institutes of Health (NIH) announced a new interactive mapping tool that showcases…
On Aug. 12, 2020, Celdara Medical announced that the National Institute of Allergy and Infectious Diseases (NIAID) of…